Mark Lee, MD, PhD

Mark Lee has been at the forefront of personalized health care for more than 15 years in leadership roles at preeminent companies in this space. Most recently, he was Senior Vice President and Global Head for Personalized Healthcare, Product Development, at Genentech/Roche, spearheading the transformation of drug development and care delivery through data at scale and technology. Previously, he was on the founding team of GRAIL, where he built one of the largest clinical research programs for early cancer detection. His previous roles also include Lead for Oncology Clinical Sciences at Google X Life Sciences, Chief Medical Officer at Boreal Genomics, and Vice President of Oncology Development at Genomic Health, where he led the successful development and validation of the oncotype diagnostic tests for colon and prostate cancers. He holds a PhD in biological chemistry and molecular pharmacology from Harvard University and an MD from Stanford University, where he completed his internal medicine training and medical oncology fellowship.